Oxytetracycline

Oxytetracycline

Clinical data
Pregnancy category	D: (USA) D: (AUS)
Routes of administration	Oral
ATC code	J01AA06 (WHO) D06AA03 (WHO) G01AA07 (WHO)
Legal status
Legal status	Prescription only
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Elimination half-life	? hours
Excretion	?
Identifiers
IUPAC name 2-(amino-hydroxy-methylidene) -4-dimethylamino -5,6,10,11,12a-pentahydroxy -6-methyl - 4,4a,5,5a,6,12a-hexahydrotetracene -1,3,12-trione
CAS Number	79-57-2
PubChem CID	5353856
DrugBank	APRD00019
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H24N2O9
Molar mass	460.434 g/mol

WikiDoc Resources for Oxytetracycline
Articles
Most recent articles on Oxytetracycline Most cited articles on Oxytetracycline Review articles on Oxytetracycline Articles on Oxytetracycline in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Oxytetracycline Images of Oxytetracycline Photos of Oxytetracycline Podcasts & MP3s on Oxytetracycline Videos on Oxytetracycline
Evidence Based Medicine
Cochrane Collaboration on Oxytetracycline Bandolier on Oxytetracycline TRIP on Oxytetracycline
Clinical Trials
Ongoing Trials on Oxytetracycline at Clinical Trials.gov Trial results on Oxytetracycline Clinical Trials on Oxytetracycline at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Oxytetracycline NICE Guidance on Oxytetracycline NHS PRODIGY Guidance FDA on Oxytetracycline CDC on Oxytetracycline
Books
Books on Oxytetracycline
News
Oxytetracycline in the news Be alerted to news on Oxytetracycline News trends on Oxytetracycline
Commentary
Blogs on Oxytetracycline
Definitions
Definitions of Oxytetracycline
Patient Resources / Community
Patient resources on Oxytetracycline Discussion groups on Oxytetracycline Patient Handouts on Oxytetracycline Directions to Hospitals Treating Oxytetracycline Risk calculators and risk factors for Oxytetracycline
Healthcare Provider Resources
Symptoms of Oxytetracycline Causes & Risk Factors for Oxytetracycline Diagnostic studies for Oxytetracycline Treatment of Oxytetracycline
Continuing Medical Education (CME)
CME Programs on Oxytetracycline
International
Oxytetracycline en Espanol Oxytetracycline en Francais
Business
Oxytetracycline in the Marketplace Patents on Oxytetracycline
Experimental / Informatics
List of terms related to Oxytetracycline

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oxytetracycline was the second of the broad-spectrum tetracycline group of antibiotics to be discovered.

History

It was first found near Pfizer laboratories in a soil sample yielding the soil actinomycete, Streptomyces rimosus by Finlay et al. In 1953, a celebrated Scottish American biochemist, Robert B Woodward, worked out the chemical structure of Oxytetracycline, enabling Pfizer to mass produce the drug under the trade name, Terramycin. This discovery by Woodward was a major advancement in Tetracycline research and paved the way for the discovery of an Oxytetracycline derivative, Doxycycline, which is one of the most popularly used antibiotics today.

Indications

Oxytetracycline, like other Tetracyclines, is used to treat many infections common and rare (see Tetracycline antibiotics group). Its better absorption profile makes it preferable to tetracycline for moderately severe acne at a dosage of 250-500mg four times a day for usually 6-8 weeks at a time, but alternatives should be sought if no improvement occurs by 3 months.

It is sometimes used to treat Spirochaetal infection,Clostridial wound infection and Anthrax in patients sensitive to Penicillin. Oxytetracycline is used to treat infections of the respiratory and urinary tracts, skin, ear, eye and Gonorrhoea although the use of Tetracyclines for such purposes has declined in recent years due to large increases in bacterial resistance to this class of drugs. The drug is particularly useful when Penicillins and/or Macrolides cannot be used due to allergy. It may be used to treat Legionnaire's Disease as a substitute for a Macrolide or Quinolone.

Oxytetracycline is especially valuable in treating Non-Specific-Urethritis, LGV, Lyme disease, Brucellosis, Cholera, Plague, Typhus, Relapsing Fever, Tulaeraemia and infections caused by Chlamydia, Mycoplasma and Rickettsia. Doxycycline is now preferred to Oxytetracycline for many of these indications because it has improved pharmacologic features.

The standard dose is 250-500mg six hourly by mouth. In particularly severe infections this dose may be increased accordingly. Occasionally, Oxytetracycline is given by intramuscular injection or topically in the form of creams, ophthalmic ointments or eye drops.

Veterinary indications

Oxytetracycline is used to control the outbreak of American Foulbrood and European Foulbrood in honeybees.

Side effects

Side effects are mainly gastrointestinal and photosensitive allergic reactions common to the tetracycline antibiotics group.
Can also damage calcium rich organs such as teeth and bones although this is very rare, sometimes causes naval cavities to erode, quite common, the BNF suggests that because of this Tetracyclines should not be used to treat pregnant or lactating women and children under 12 except in certain conditions where it has been approved by a specialist because there are no obvious substitutes. Candidiasis (Thrush) is not uncommon following treatment with broad spectrum antibiotics.

Formulation

Tablets containing 250mg Tablets of Oxytetracycline as the dihydrate.